Technical Analysis for HOWL - Werewolf Therapeutics, Inc.

Grade Last Price % Change Price Change
F 11.63 0.26% 0.03
HOWL closed up 0.26 percent on Friday, May 14, 2021, on 33 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical HOWL trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
New 52 Week Closing Low Bearish 0.26%
Hot IPO Pullback Bullish Swing Setup 0.26%
New 52 Week Low Weakness 0.26%
Down 3 Days in a Row Weakness 0.26%
Down 4 Days in a Row Weakness 0.26%
New 52 Week Closing Low Bearish -9.91%
Hot IPO Pullback Bullish Swing Setup -9.91%
NR7 Range Contraction -9.91%
Older End-of-Day Signals for HOWL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 12 hours ago
Reversed from Down about 15 hours ago
Gap Down Closed about 15 hours ago
Up 5% about 15 hours ago
Up 3% about 15 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Werewolf Therapeutics, Inc. Description

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It offers PREDATOR, a platform of protein engineering technology to design and engineer the future of immuno-oncology biotherapeutics for patients. The company's lead product candidates include WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. It also develops WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.


Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Solid Tumors Treatment Of Cancer Health Sciences Lymphoma Cancer Immunotherapy Hematologic Malignancies Advanced Solid Tumors Metastatic Solid Tumors

Is HOWL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 23.99
52 Week Low 11.25
Average Volume 225,373
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 13.91
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.78
Resistance 3 (R3) 12.87 12.57 12.59
Resistance 2 (R2) 12.57 12.28 12.53 12.53
Resistance 1 (R1) 12.10 12.09 12.33 12.01 12.46
Pivot Point 11.80 11.80 11.92 11.76 11.80
Support 1 (S1) 11.33 11.51 11.57 11.25 10.80
Support 2 (S2) 11.03 11.32 10.99 10.73
Support 3 (S3) 10.56 11.03 10.67
Support 4 (S4) 10.48